These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 11723375)
21. Phase 2 trial design in neuro-oncology revisited: a report from the RANO group. Galanis E; Wu W; Cloughesy T; Lamborn K; Mann B; Wen PY; Reardon DA; Wick W; Macdonald D; Armstrong TS; Weller M; Vogelbaum M; Colman H; Sargent DJ; van den Bent MJ; Gilbert M; Chang S Lancet Oncol; 2012 May; 13(5):e196-204. PubMed ID: 22554547 [TBL] [Abstract][Full Text] [Related]
22. Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab. Siegal T; Charbit H; Paldor I; Zelikovitch B; Canello T; Benis A; Wong ML; Morokoff AP; Kaye AH; Lavon I J Neurosurg; 2016 Oct; 125(4):1008-1015. PubMed ID: 26799295 [TBL] [Abstract][Full Text] [Related]
23. [Chemotherapy of brain tumors]. García del Muro Solans J; Martí Massó JF Neurologia; 1988; 3(1):19-25. PubMed ID: 3078754 [No Abstract] [Full Text] [Related]
24. Perioperative clinical trials for glioma: Raising the bar. Mweempwa A; Rosenthal MA; Dimou J; Drummond KJ; Whittle JR J Clin Neurosci; 2021 Jul; 89():144-150. PubMed ID: 34119258 [TBL] [Abstract][Full Text] [Related]
25. Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results. Berendsen S; Broekman M; Seute T; Snijders T; van Es C; de Vos F; Regli L; Robe P Expert Opin Investig Drugs; 2012 Sep; 21(9):1391-415. PubMed ID: 22668241 [TBL] [Abstract][Full Text] [Related]
27. In reference to lamborn et Al. (Neuro-oncology. 2008;10:162-170). Meyers CA; Lamborn KR; Prados MD Neuro Oncol; 2008 Dec; 10(6):1171-2. PubMed ID: 18725461 [No Abstract] [Full Text] [Related]
28. The effect of anticonvulsant drugs on blood levels of methotrexate. Riva M; Landonio G; Defanti CA; Siena S J Neurooncol; 2000 Jul; 48(3):249-50. PubMed ID: 11100823 [TBL] [Abstract][Full Text] [Related]
29. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV. Levin VA Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490 [No Abstract] [Full Text] [Related]
30. Childhood brain tumors: current status of clinical trials in newly diagnosed and recurrent disease. Allen JC Pediatr Clin North Am; 1985 Jun; 32(3):633-51. PubMed ID: 3889800 [TBL] [Abstract][Full Text] [Related]
31. Second temporal remission in a malignant glioma with trofosfamide and etoposide: a case report. Wolff JE; Boos J; Krähling KH; Jürgens H Klin Padiatr; 1996; 208(4):190-2. PubMed ID: 8776706 [TBL] [Abstract][Full Text] [Related]
32. Advances in brain tumor surgery. Asthagiri AR; Pouratian N; Sherman J; Ahmed G; Shaffrey ME Neurol Clin; 2007 Nov; 25(4):975-1003, viii-ix. PubMed ID: 17964023 [TBL] [Abstract][Full Text] [Related]
33. [The potentials for the use of highly dispersed iron in neuro-oncology]. Shvets TM; Kushchevskaia NF; Grigor'eva EA Lik Sprava; 1997; (3):92-4. PubMed ID: 9377365 [TBL] [Abstract][Full Text] [Related]
35. The George C. Cotzias Laboratory of Neuro-Oncology. Hadden JW Clin Bull; 1980; 10(4):167-71. PubMed ID: 6260397 [No Abstract] [Full Text] [Related]